A panelist discusses how CD4 counts serve as measures of immune system status that typically increase by about 200 in the first year of antiretroviral therapy. Although there can be laboratory ...

T-cell profiles derived from blood and renal biopsy may be novel biomarkers of lupus nephritis treatment response, study findings suggest.

The authors compared the CD4+ T-cell counts and HIV-1 RNA viral loads of 383 patients who were either mono-infected with HIV or co-infected with HTLV-1/HIV. They confirmed that co-infected patients ...

July 30, 2010 (Vienna, Austria) — Although initiation of highly active antiretroviral therapy (HAART) against HIV is associated with a lower risk for progression to AIDS, and a lower risk for ...

Idiopathic CD4 T Lymphocytopenia (ICL) is a rare immunological syndrome defined by persistently low CD4+ T-cell counts, typically below 300 cells/µL, in the absence of human immunodeficiency virus ...

This study analyzed lung infections in immunocompromised patients admitted to the ICU and explored how different levels of CD4⁺T-cell depletion are associated with pathogen distribution and ...

Phase I study to evaluate the safety and efficacy of switchable CAR-T cell therapy with FY001 and CART001 in patients with refractory CD20-positive B-cell non-Hodgkin lymphoma (EPOC1803). CD4 ≥124.5 ...

Higher levels of CD4-positive naïve T cells in patients receiving CAR T-cell therapy for multiple myeloma are associated with longer PFS, suggesting T-cell composition may serve as a biomarker to ...